Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/52559| Title: | Position statement on the management of pregnancy in sickle cell disease. | Authors: | Yue M.;Mason K.;Rowlands S.;Kaplan Z.;Kennedy D.;Kidson-Gerber G. | Monash Health Department(s): | Haematology | Institution: | (Yue) Department of Haematology, Mater Health Service, Brisbane, QLD, Australia (Yue) School of Medicine, University of Queensland, Brisbane, QLD, Australia (Mason) Department of Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia (Mason) Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia (Rowlands) Department of Maternal Fetal Medicine, Royal Women's Hospital, Melbourne, VIC, Australia (Kaplan) Monash Haematology, Monash Health, Melbourne, VIC, Australia (Kaplan) Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia (Kennedy) Royal Hospital for Women, Randwick Campus, Sydney, NSW, Australia (Kennedy, Kidson-Gerber) Schools of Medicine and Women's and Children's Health, Prince of Wales Hospital and Royal Hospital for Women Clinical School, University of NSW, Sydney, NSW, Australia (Kidson-Gerber) Department of Haematology, NSW Health Pathology, Prince of Wales Hospital and Royal Hospital for Women, Randwick Campus, Sydney, NSW, Australia |
Issue Date: | 3-Oct-2024 | Copyright year: | 2024 | Publisher: | John Wiley and Sons Inc | Place of publication: | Australia | Publication information: | Australian and New Zealand Journal of Obstetrics and Gynaecology. (no pagination), 2024. Date of Publication: 2024. | Journal: | Australian and New Zealand Journal of Obstetrics and Gynaecology | Abstract: | Sickle cell disease (SCD) is a hereditary haemoglobinopathy which causes multi-organ dysfunction. Pregnancies in SCD are high risk with significant maternal and fetal morbidity and mortality, including vaso-occlusive crises, thrombosis, anaemia, placental insufficiency, fetal growth restriction, preterm birth and medication effects. High level evidence on this topic is lacking. The Australian Sickle Cell Disease Working Group has reviewed international guidelines on this topic and provide an up-to-date and structured approach to the pre-conception, antenatal, birth and post-partum management of these women. Early and comprehensive multidisciplinary care involving experienced clinicians is recommended.Copyright © 2024 The Author(s). Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists. | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/ajo.13888 | PubMed URL: | 39333023 [https://www.ncbi.nlm.nih.gov/pubmed/?term=39333023] | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/52559 | Type: | Article | Subjects: | anemia hemoglobinopathy intrauterine growth retardation placenta insufficiency |
Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.